vanadates has been researched along with B-Cell Lymphoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ozer, Z; Uckun, F; Vassilev, A | 1 |
Grosmaire, L; Ledbetter, JA; Myrdal, S; Schieven, GL; Wahl, AF | 1 |
Furniss, MJ; Miller, SC | 1 |
Avraham, S; Brubaker, SA; Chernock, RD; Ganju, RK; Groopman, JE | 1 |
4 other study(ies) available for vanadates and B-Cell Lymphoma
Article | Year |
---|---|
Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress.
Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Apoptosis; Chickens; Enzyme Inhibitors; Female; Humans; Leukemia, B-Cell; Lymphoma, B-Cell; Neoplasm Proteins; Oxidative Stress; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Recombinant Proteins; STAT3 Transcription Factor; Tumor Cells, Cultured; Vanadates | 2007 |
Lineage-specific induction of B cell apoptosis and altered signal transduction by the phosphotyrosine phosphatase inhibitor bis(maltolato)oxovanadium(IV).
Topics: Animals; Apoptosis; B-Lymphocytes; Calcium; Cell Line; Cytoplasm; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Immunoglobulin M; Kinetics; Leukemia, Promyelocytic, Acute; Leukemia, T-Cell; Lymphocyte Activation; Lymphoma, B-Cell; Mice; Phospholipases; Phytohemagglutinins; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proteins; Pyrones; Receptors, Antigen, B-Cell; Receptors, Antigen, T-Cell; Receptors, Interleukin-2; Signal Transduction; Tumor Cells, Cultured; TYK2 Kinase; Vanadates | 1995 |
Bruton's tyrosine kinase activity and inositol 1,4,5-trisphosphate production are not altered in DT40 lymphoma B cells exposed to power line frequency magnetic fields.
Topics: Agammaglobulinaemia Tyrosine Kinase; Antibodies; Electromagnetic Fields; Enzyme Activation; Enzyme Induction; Humans; Immunoglobulin M; Inositol 1,4,5-Trisphosphate; Lymphoma, B-Cell; Phosphorylation; Protein-Tyrosine Kinases; Tumor Cells, Cultured; Vanadates | 1998 |
Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk.
Topics: Adaptor Proteins, Signal Transducing; Chemokine CCL4; Chemotaxis, Leukocyte; Enzyme Activation; Enzyme Inhibitors; Enzyme Precursors; Focal Adhesion Kinase 2; GRB2 Adaptor Protein; Humans; Intracellular Signaling Peptides and Proteins; Lymphoma, B-Cell; Macrophage Inflammatory Proteins; Mutagenesis; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proteins; Receptors, CCR5; Recombinant Proteins; Signal Transduction; Syk Kinase; T-Lymphocytes; Transfection; Tumor Cells, Cultured; Vanadates | 2000 |